NIH-funded research R01 grant

Multi-omics study of protecting against frailty in older adults

Official title: Multi-omics approach to frailty resilience

Funded at Albert Einstein College of Medicine · NIH-11393180 · Data updated 2026-11-12

A multi-omics study looks for biological factors linked to resilience against frailty in older adults, especially in families with exceptional longevity.

More Resilience research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionAlbert Einstein College of Medicine
NIH-funded
Lab location1 site (Bronx, United States)
Project startJuly 1, 2014
Project endJune 30, 2029
Funding year2026
Award (this year)$700,835
NIH project number5R01AG044829-10
Project IDNIH-11393180 on NIH RePORTER

Who could benefit from this research

Could help

Older adults, especially those from families with exceptional longevity, who can participate in genetic, epigenetic, and proteomic analyses.

Less likely to help

Individuals not contributing samples or data, or those outside the targeted age and family longevity criteria, may not directly benefit.

What this research studies

This project uses genomics, epigenomics, and proteomics to find molecular factors that help people delay frailty. Researchers will study how these factors differ in people who stay robust despite aging and in families with long lives, using a new Frailty Resilience Score to measure protection against frailty. By combining multiple biological layers, the study aims to uncover markers that could guide future therapies to preserve independence in aging. The work brings together experts from different fields to interpret complex data and identify potential targets for intervention.

Why it matters

Potential benefit: If successful, findings could lead to new biomarkers and therapies that help older adults stay independent longer.

How similar studies have gone: Previous work has highlighted complex, multi-omics patterns associated with aging and frailty, but identifying protective resilience factors is still emerging.

Where this research is happening

  • Albert Einstein College of Medicine
    Bronx, United States
    Active

Researchers

  • Principal investigator: Milman, Sofiya — Albert Einstein College of Medicine
  • Study coordinator: Milman, Sofiya

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.